Alembic Pharma gets tentative USFDA nod for fesoterodine fumarate extended-release tablets

The approval by the US Food Drug Administration (USFDA) for the abbreviated new drug application (ANDA) for fesoterodine fumarate extended-release tablets is for strengths of 4 mg and 8 mg, the company said in a statement.

from Moneycontrol Business News https://ift.tt/BaDrMtVoP